磁共振成像用于评估早期乳腺癌患者机器人辅助保留乳头乳房切除术后残留乳腺组织
这项前瞻性先导研究纳入2017年3月至2022年5月在彰化基督教医院因乳腺癌行机器人辅助保留乳头乳房切除术的105例患者,其中43例(54次手术)有术前MRI者接受术后乳腺MRI评估残留乳腺组织。54次手术中7次(13.0%)检出残留乳腺组织,最常见位于乳头乳晕复合体后方(7例中5例)。作者认为机器人辅助保留乳头乳房切除术似乎不增加残留乳腺组织患病率,乳腺MRI作为无创工具评估残留乳腺组织的位置和存在具有可行性。
要点
- 机器人辅助保留乳头乳房切除术后54次手术中7次(13.0%)MRI检出残留乳腺组织。
- 残留乳腺组织最常见位于乳头乳晕复合体后方(7例中5例,71.4%)。
- 7例残留乳腺组织中另2例(28.6%)位于上内象限。
核心结论
- 机器人辅助保留乳头乳房切除术似乎不增加残留乳腺组织患病率,乳腺MRI作为无创影像工具评估残留乳腺组织存在与位置具有可行性。
研究设计与样本
- 前瞻性先导研究,2017年3月至2022年5月彰化基督教医院因乳腺癌行机器人辅助保留乳头乳房切除术的105例患者中,43例有术前MRI者(54次手术)接受术后乳腺MRI评估残留乳腺组织。
关键影像表现/征象
- 54次乳房切除术中7次(13.0%)MRI检出残留乳腺组织,包括48次治疗性乳房切除术中6次和6次预防性乳房切除术中1次。
- 残留乳腺组织最常见位于乳头乳晕复合体后方(7例中5例,71.4%)。
- 另2例残留乳腺组织(7例中2例,28.6%)位于上内象限。
临床应用与阅片要点
- 作者认为乳腺MRI可作为无创影像工具用于评估机器人辅助保留乳头乳房切除术后残留乳腺组织的有无与位置。
局限性
- 原文指出关于机器人辅助保留乳头乳房切除术后残留乳腺组织的前瞻性研究有限。
- 原文指出残留乳腺组织带来局部复发或新发癌症的未知风险。
- 本研究为前瞻性先导研究,43例患者有术前MRI并纳入术后MRI评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Prospective studies on postoperative residual breast tissue (RBT) after robotic-assisted nipple-sparing mastectomy (R-NSM) for breast cancer are limited. RBT presents an unknown risk of local recurrence or the development of new cancer after curative or risk-reducing mastectomies. This study investigated the technical feasibility of using magnetic resonance imaging (MRI) to evaluate RBT after R-NSM in women with breast cancer.
MATERIALS AND METHODS: In this prospective pilot study, 105 patients, who underwent R-NSM for breast cancer at Changhua Christian Hospital between March 2017 and May 2022, were subjected to postoperative breast MRI to evaluate the presence and location of RBT. The postoperative MRI scans of 43 patients (age, 47.8 ± 8.5 years), with existing preoperative MRI scans, were evaluated for the presence and location of RBT. In total, 54 R-NSM procedures were performed. In parallel, we reviewed the literature on RBT after nipple-sparing mastectomy, considering its prevalence.
RESULTS: RBT was detected in 7 (13.0%) of the 54 mastectomies (6 of the 48 therapeutic mastectomies and 1 of the 6 prophylactic mastectomies). The most common location for RBT was behind the nipple-areolar complex (5 of 7 [71.4%]). Another RBT was found in the upper inner quadrant (2 of 7 [28.6%]). Among the six patients who underwent RBT after therapeutic mastectomies, one patient developed a local recurrence of the skin flap. The other five patients with RBT after therapeutic mastectomies remained disease-free.
CONCLUSION: R-NSM, a surgical innovation, does not seem to increase the prevalence of RBT, and breast MRI showed feasibility as a noninvasive imaging tool for evaluating the presence and location of RBT.
引用
- Wu WP, Lai HW, Liao CY, et al. Use of Magnetic Resonance Imaging for Evaluating Residual Breast Tissue After Robotic-Assisted Nipple-Sparing Mastectomy in Women With Early Breast Cancer. Korean J Radiol. 2023. PMID: 37404106. doi:10.3348/kjr.2022.0708
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。